Podcasts Health Empowered Patient Podcast Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy Eradicating These Brain Tumors with Dr. Marc Hedrick PLUS Therapeutics

Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy Eradicating These Brain Tumors with Dr. Marc Hedrick PLUS Therapeutics

Published: May 10, 2021, 10:36 p.m.

Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery.  This approach allows the neurosurgeon to put catheters directly into the brain by using stereotactic brain biopsy, imaging and software driven planning bypassing the normal structures and delivering 20 or more times the amount of radiation than can be delivered by external beam radiation.

@PLUStxinc #braincancer #braintumor #GBM #Glioblastoma #RNL #Oncology #RareDisease #Neurosurgery #Nanotechnology #radiotherapy #pharmaceuticals #NIH #FDA #OrphanDrug #FastTrack $PSTV

PLUSTherapeutics.com

Download the transcript here

PLUS Therapeutics